Replies to post #9315 on Inovio Pharmaceuticals Inc (INO)

[johan31]

Novartis & Novavax both heavily represented at this up coming RSV conference in Portugal. Novavax currently in a phase2 trial for RSV using a nanoparticle vaccine approach and Novartis in preclinical RSV....

http://www.novavax.com/go.cfm?do=Page.View&pid=13
http://www.novartisvaccines.com/products-diseases/pipeline.shtml
http://www.meetingsmanagement.co.uk/index.php?option=com_content&view=article&id=110&Itemid=226